Abbott licenses biomarkers for use in differentiating aggressive from nonaggressive prostate cancer
17 April 2012
Detection of gene abnormalities may help men determine the best approach to treatment...
Industry news
Novo Nordisk breaks ground on new plant in Russia
17 April 2012
Novo Nordisk broke ground on a new USD 100 million plant that will formulate and fill modern insulin into Novo Nordisk’s Penfill® cartridges...
Abbott’s investigational treatment for advanced Parkinson’s Disease demonstrates positive results in Phase 3 clinical trial
17 April 2012
Statistically significant improvements...
Lilly Diabetes and Walgreens launch diabetes hypoglycemia awareness campaign
16 April 2012
Lilly Diabetes & Walgreens to help combat the problem of hypoglycemia unawareness...
Owen Mumford opens office in Shanghai
16 April 2012
Owen Mumford, one of the UK’s largest manufacturers of medical devices has opened its doors for business in China...
Exclusive worldwide agreement to develop and commercialize Phase III cancer candidate vintafolide (EC145)
16 April 2012
Vintafolide is currently being evaluated in a Phase III clinical trial...
GSK provides update on corporate responsibility commitments in 2011 report
11 April 2012
GlaxoSmithKline has published its Corporate Responsibility Report...
Abbott’s HUMIRA® (adalimumab) approved in Europe for treatment of ulcerative colitis (UC)
11 April 2012
The European Commission has approved HUMIRA®...
Corning to acquire majority of BD Discovery Labware
10 April 2012
Corning Incorporated has reached a definitive agreement with BD to acquire the majority of its Discovery Labware unit...
Amgen to acquire privately held KAI Pharmaceuticals
10 April 2012
Amgen and KAI Pharmaceuticals have announced an agreement under which Amgen will acquire KAI...
Abbott receives approval for next-generation XIENCE PRIME™ drug eluting stent in Japan
9 April 2012
Abbott announced it has received approval from the Japanese MHLW...
In-depth focus:
Mass Spectrometry
This free to view Mass Spectrometry in-depth focus is sponsored by Waters, Bruker, Protea and Dr. Hochmuth and contains the following articles:
- Mass spectrometry in drug discovery - Proteomics, small molecules and metablomics
- Quantification of membrane drug transporters and application in drug discovery and development
- Anthony Bristow, AstraZeneca, poses the questions for our Mass Spectrometry Leaders Roundtable
Company directory
ABB Analytical Measurements | Almac | B&W Tek, Inc. | BASF | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Optics | CAMO Software AS | Catalent Pharma Solutions | Chemspec Europe Ltd | CI Precision | Cisbio Bioassays | EMD Millipore | GE Analytical Instruments | Gerresheimer Group | HACH LANGE GMBH | HORIBA Scientific | I Holland Limited | Lonza | Merck Millipore | Pall Life Sciences | Patheon Inc | Phenomenex | Porvair Sciences Ltd | Randox Pharma Services | Rapid Micro Biosystems | Realia | Roche | rommelag® | Umetrics |
Login to access exclusive content